<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39380070</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2049-9957</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Infectious diseases of poverty</Title><ISOAbbreviation>Infect Dis Poverty</ISOAbbreviation></Journal><ArticleTitle>Global burden of viral infectious diseases of poverty based on Global Burden of Diseases Study 2021.</ArticleTitle><Pagination><StartPage>71</StartPage><MedlinePgn>71</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">71</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40249-024-01234-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Viral infectious diseases of poverty (vIDPs) remain a significant global health challenge. Despite their profound impact, the burden of these diseases is not comprehensively quantified. This study aims to analyze the global burden of six major vIDPs, including coronavirus disease 2019 (COVID-19), HIV/AIDS, acute hepatitis, dengue, rabies, and Ebola virus disease (EVD), using data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021 (GBD 2021).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Following the GBD 2021 framework, we analyzed the incidence, mortality, and disability-adjusted life years (DALYs) of the six vIDPs across 204 countries and territories from 1990 to 2021. We examined the association between the Socio-Demographic Index (SDI) and the burden of vIDPs. All estimates were reported as numbers and rates per 100,000 population, calculated using the Bayesian statistical model employed by GBD 2021, with 95% uncertainty intervals (UI).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 2021, vIDPs caused approximately 8.7 million deaths and 259.2 million DALYs, accounting for 12.8% and 9.0% of the global all-cause totals, respectively. Globally, the burden of vIDPs varied significantly: COVID-19 caused around 7.9 million (95% UI: 7.5, 8.4) deaths and 212.0 million (95% UI 197.9, 234.7) DALYs in 2021. Acute hepatitis had the second-highest age-standardized incidence rate, with 3411.5 (95% UI: 3201.8, 3631.3) per 100,000 population, while HIV/AIDS had a high age-standardized prevalence rate, with 483.1 (95% UI: 459.0, 511.4) per 100,000 population. Dengue incidence cases rose from 26.5 million (95% UI: 3.9, 51.9) in 1990 to 59.0 million (95% UI: 15.5, 106.9) in 2021. Rabies, although reduced in prevalence, continued to pose a significant mortality risk. EVD had the lowest overall burden but significant outbreak impacts. Age-standardized DALY rates for vIDPs were significantly negatively correlated with SDI: acute hepatitis (r = -0.8, P &lt; 0.0001), rabies (r = -0.7, P &lt; 0.0001), HIV/AIDS (r = -0.6, P &lt; 0.0001), COVID-19 (r = -0.5, P &lt; 0.0001), dengue (r = -0.4, P &lt; 0.0001), and EVD (r = -0.2, P &lt; 0.005).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">VIDPs pose major public health challenges worldwide, with significant regional, age, and gender disparities. The results underscore the need for targeted interventions and international cooperation to mitigate the burden of these diseases. Policymakers can use these findings to implement cost-effective interventions and improve health outcomes, particularly in regions with high or increasing burdens.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Xin-Chen</ForeName><Initials>XC</Initials><AffiliationInfo><Affiliation>School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of One Health, Shanghai Jiao Tong University, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Yan-Yan</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of One Health, Shanghai Jiao Tong University, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Qi-Yu</ForeName><Initials>QY</Initials><AffiliationInfo><Affiliation>School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of One Health, Shanghai Jiao Tong University, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jing-Shu</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of One Health, Shanghai Jiao Tong University, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ran</LastName><ForeName>Jin-Jun</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Le-Fei</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of One Health, Shanghai Jiao Tong University, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiao-Xi</ForeName><Initials>XX</Initials><Identifier Source="ORCID">0000-0002-7710-9587</Identifier><AffiliationInfo><Affiliation>School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China. zhangxiaoxi@sjtu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of One Health, Shanghai Jiao Tong University, Shanghai, People's Republic of China. zhangxiaoxi@sjtu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>72204160</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>21410750200</GrantID><Agency>International Joint Laboratory on Tropical Diseases Control in Greater Mekong Subregion</Agency><Country /></Grant><Grant><GrantID>NHCKFKT2022-16</GrantID><Agency>Open Research Project of the Key Laboratory of Parasite Pathogen and Vector Biology of National Health Commission of the People's Republic of China</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Infect Dis Poverty</MedlineTA><NlmUniqueID>101606645</NlmUniqueID><ISSNLinking>2049-9957</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071219" MajorTopicYN="Y">Global Burden of Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011203" MajorTopicYN="Y">Poverty</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000087509" MajorTopicYN="N">Disability-Adjusted Life Years</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Disability-adjusted life years</Keyword><Keyword MajorTopicYN="N">Global Burden of Disease 2021</Keyword><Keyword MajorTopicYN="N">Socio-Demographic Index</Keyword><Keyword MajorTopicYN="N">Viral infectious diseases of poverty</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>7</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>23</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39380070</ArticleId><ArticleId IdType="pmc">PMC11459951</ArticleId><ArticleId IdType="doi">10.1186/s40249-024-01234-z</ArticleId><ArticleId IdType="pii">10.1186/s40249-024-01234-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Murray CJ, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7566194</ArticleId><ArticleId IdType="pubmed">33069327</ArticleId></ArticleIdList></Reference><Reference><Citation>Collaborators GRF. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6227755</ArticleId><ArticleId IdType="pubmed">30496105</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2019 Viewpoint Collaborators. Five insights from the Global Burden of Disease Study 2019. Lancet. 2020;396(10258): 1135-1159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116361</ArticleId><ArticleId IdType="pubmed">33069324</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou XN. Infectious Diseases of Poverty: progress achieved during the decade gone and perspectives for the future. Infect Dis Poverty. 2022;11(1):1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8723998</ArticleId><ArticleId IdType="pubmed">34983679</ArticleId></ArticleIdList></Reference><Reference><Citation>Jebril N. World Health Organization declared a pandemic public health menace: a systematic review of the coronavirus disease 2019 “COVID-19”. Available at SSRN 3566298. 2020.</Citation></Reference><Reference><Citation>UNAIDS. Global HIV &amp; AIDS statistics—2020 fact sheet 2020. https://www.unaids.org/en/resources/fact-sheet. Accessed 2 June 2024.</Citation></Reference><Reference><Citation>Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7567026</ArticleId><ArticleId IdType="pubmed">33069326</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Hepatitis 2020. https://www.who.int/health-topics/hepatitis. Accessed 2 June 2024.</Citation></Reference><Reference><Citation>GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–1994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6227755</ArticleId><ArticleId IdType="pubmed">30496105</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Dengue and severe dengue 2020. https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue. Accessed 2 June 2024.</Citation></Reference><Reference><Citation>WHO. Rabies 2020. https://www.who.int/news-room/fact-sheets/detail/rabies. Accessed 2 June 2024.</Citation></Reference><Reference><Citation>WHO. Ebola virus disease 2020. https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease. Accessed 2 June 2024.</Citation></Reference><Reference><Citation>World Bank. The Global Economic Outlook During the COVID-19 Pandemic: A Changed World 2020. https://www.worldbank.org/en/news/feature/2020/06/08/the-global-economic-outlook-during-the-covid-19-pandemic-a-changed-world. Accessed 2 June 2024.</Citation></Reference><Reference><Citation>WHO. Mental health and COVID-19 2020. https://www.who.int/teams/mental-health-and-substance-use/covid-19. Accessed 2 June 2024.</Citation></Reference><Reference><Citation>Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5605509</ArticleId><ArticleId IdType="pubmed">28919117</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133–61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11122111</ArticleId><ArticleId IdType="pubmed">38642570</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2100–32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11126520</ArticleId><ArticleId IdType="pubmed">38582094</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotez PJ, Fenwick A, Molyneux D. The new COVID-19 poor and the neglected tropical diseases resurgence. Infect Dis Poverty. 2021;10(1):10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7843239</ArticleId><ArticleId IdType="pubmed">33509283</ArticleId></ArticleIdList></Reference><Reference><Citation>Van de Vuurst P, Escobar LE. Climate change and infectious disease: a review of evidence and research trends. Infect Dis Poverty. 2023;12(1):51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10186327</ArticleId><ArticleId IdType="pubmed">37194092</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Quam MBM, Zhang T, Sang S. Global burden for dengue and the evolving pattern in the past 30 years. J Travel Med. 2021;28(8):taab146.</Citation><ArticleIdList><ArticleId IdType="pubmed">34510205</ArticleId></ArticleIdList></Reference><Reference><Citation>van Wyngaard A. A pandemic of inequality: reflections on AIDS and COVID-19 in the southern African context. Afr J AIDS Res. 2022;21(2):152–61.</Citation><ArticleIdList><ArticleId IdType="pubmed">35901303</ArticleId></ArticleIdList></Reference><Reference><Citation>Moyo E, Moyo P, Murewanhema G, Mhango M, Chitungo I, Dzinamarira T. Key populations and sub-Saharan Africa’s HIV response. Front Public Health. 2023;11:1079990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10229049</ArticleId><ArticleId IdType="pubmed">37261232</ArticleId></ArticleIdList></Reference><Reference><Citation>Eze P, Lawani LO, Agu UJ, Acharya Y. Catastrophic health expenditure in sub-Saharan Africa: systematic review and meta-analysis. Bull World Health Organ. 2022;100(5):337–51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047424</ArticleId><ArticleId IdType="pubmed">35521041</ArticleId></ArticleIdList></Reference><Reference><Citation>Colón-González FJ, Gibb R, Khan K, Watts A, Lowe R, Brady OJ. Projecting the future incidence and burden of dengue in Southeast Asia. Nat Commun. 2023;14(1):5439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10482941</ArticleId><ArticleId IdType="pubmed">37673859</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsheten T, Gray DJ, Clements ACA, Wangdi K. Epidemiology and challenges of dengue surveillance in the WHO South-East Asia Region. Trans R Soc Trop Med Hyg. 2021;115(6):583–99.</Citation><ArticleIdList><ArticleId IdType="pubmed">33410916</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao W, Zhao J, Chen Y, Liu X, Xu C, Zhang J, et al. Global burden and trends of acute viral hepatitis among children and adolescents from 1990 to 2019: a systematic analysis of the Global Burden of Disease Study 2019. Hepatol Int. 2024;18(3):917–28.</Citation><ArticleIdList><ArticleId IdType="pubmed">38528292</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133–46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin JX, Agbana YL, Sun ZS, Fei SW, Zhao HQ, Zhou XN, et al. Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis. Infect Dis Poverty. 2023;12(1):43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10123579</ArticleId><ArticleId IdType="pubmed">37095536</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Z, Zhan J, Chen L, Chen H, Cheng S. Global, regional, and national dengue burden from 1990 to 2017: a systematic analysis based on the global burden of disease study 2017. EClinicalMedicine. 2021;32: 100712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7910667</ArticleId><ArticleId IdType="pubmed">33681736</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng DY, Li JM, Lin S, Dong X, You J, Xing QQ, et al. Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990–2019. J Hepatol. 2021;75(3):547–56.</Citation><ArticleIdList><ArticleId IdType="pubmed">33961940</ArticleId></ArticleIdList></Reference><Reference><Citation>Onyeneho NG, Aronu NI, Igwe I, Okeibunor J, Diarra T, Anoko JN, et al. The impact of the Ebola virus disease epidemic among women in the provinces of North Kivu and Ituri in the Democratic Republic of the Congo. J Immunol Sci. 2023;Suppl 3:11–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615619</ArticleId><ArticleId IdType="pubmed">38333354</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt-Sane M, Nielsen J, Chikombero M, Lubowa D, Lwanga M, Gamusi J, et al. Gendered care at the margins: Ebola, gender, and caregiving practices in Uganda’s border districts. Glob Public Health. 2022;17(6):899–911.</Citation><ArticleIdList><ArticleId IdType="pubmed">33517846</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian X, Chen J, Wang X, Xie Y, Zhang X, Han D, et al. Global, regional, and national HIV/AIDS disease burden levels and trends in 1990–2019: a systematic analysis for the global burden of disease 2019 study. Front Public Health. 2023;11:1068664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9975742</ArticleId><ArticleId IdType="pubmed">36875364</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng P, Chen M, Si L. Temporal trends in inequalities of the burden of HIV/AIDS across 186 countries and territories. BMC Public Health. 2023;23(1):981.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10215035</ArticleId><ArticleId IdType="pubmed">37237365</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayman DTS, Adisasmito WB, Almuhairi S, Behravesh CB, Bilivogui P, Bukachi SA, et al. Developing One Health surveillance systems. One Health. 2023;17:100617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10665171</ArticleId><ArticleId IdType="pubmed">38024258</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegegne HA, Freeth FTA, Bogaardt C, Taylor E, Reinhardt J, Collineau L, et al. Implementation of One Health surveillance systems: Opportunities and challenges—lessons learned from the OH-EpiCap application. One Health. 2024;18:100704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10940803</ArticleId><ArticleId IdType="pubmed">38496337</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XX, Lederman Z, Han LF, Schurer JM, Xiao LH, Zhang ZB, et al. Towards an actionable One Health approach. Infect Dis Poverty. 2024;13(1):28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11010417</ArticleId><ArticleId IdType="pubmed">38610035</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen T, Welburn SC, Sun L, Yang GJ. Progress towards dog-mediated rabies elimination in PR China: a scoping review. Infect Dis Poverty. 2023;12(1):30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10077633</ArticleId><ArticleId IdType="pubmed">37024944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X, Wang Y, Zou Y, Tu J, Tang W, Yu R, et al. Associations of socioeconomic status with infectious diseases mediated by lifestyle, environmental pollution and chronic comorbidities: a comprehensive evaluation based on UK Biobank. Infect Dis Poverty. 2023;12(1):5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9885698</ArticleId><ArticleId IdType="pubmed">36717939</ArticleId></ArticleIdList></Reference><Reference><Citation>Duamor CT, Hampson K, Lankester F, Lugelo A, Changalucha J, Lushasi KS, et al. Integrating a community-based continuous mass dog vaccination delivery strategy into the veterinary system of Tanzania: A process evaluation using normalization process theory. One Health. 2023;17:100575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10272491</ArticleId><ArticleId IdType="pubmed">37332884</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva RI, Chaves LB, Dos Ramos SS, Katz ISS, Fernandes ER, Neto RC, et al. Seroepidemiological survey to cell culture rabies vaccines (CCRV) in Brazil. One Health. 2024;18:100713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10978520</ArticleId><ArticleId IdType="pubmed">38559437</ArticleId></ArticleIdList></Reference><Reference><Citation>Dionne-Odom J, Njei B, Tita ATN. Elimination of vertical transmission of Hepatitis B in Africa: a review of available tools and new opportunities. Clin Ther. 2018;40(8):1255–67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6123260</ArticleId><ArticleId IdType="pubmed">29983265</ArticleId></ArticleIdList></Reference><Reference><Citation>Penazzato M, Irvine C, Vicari M, Essajee SM, Sharma A, Puthanakit T, et al. A global research agenda for pediatric HIV. J Acquir Immune Defic Syndr. 2018;78(1):S10–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6075892</ArticleId><ArticleId IdType="pubmed">29994914</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2162–203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11120204</ArticleId><ArticleId IdType="pubmed">38762324</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>